The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.

NUKLEONIKA, published by SCIENDO, is a leading open access journal that has been serving the scientific community since its establishment in 1968. Focused on the domains of Nuclear and High Energy Physics, Condensed Matter Physics, and Nuclear Energy and Engineering, this journal provides a platform for innovative research and technological advancements in a variety of interdisciplinary fields. With an impressive history of publications and a current Q3 ranking in several categories, including Safety, Risk, Reliability and Quality and Waste Management and Disposal, NUKLEONIKA is recognized for its significant contributions to scientific discourse. Open access since 2014, the journal ensures that all research outputs are freely available, facilitating broad dissemination and accessibility for researchers, professionals, and students alike. Located in the heart of Warsaw, Poland, NUKLEONIKA aims to inspire collaborative efforts and foster a deeper understanding of complex physical phenomena and their practical implications.

PHYSICS IN MEDICINE AND BIOLOGY is a prestigious journal published by IOP Publishing Ltd, with a storied history dating back to 1956 and extending through 2024. This internationally recognized journal caters to the interdisciplinary fields of medical physics and bioengineering, making significant contributions to the research and development of advanced diagnostic and therapeutic technologies. It holds an impressive Q1 ranking in both Radiological and Ultrasound Technology and Radiology, Nuclear Medicine and Imaging categories, reflecting its critical role in disseminating high-quality research. With a significant focus on merging the principles of physics with advancements in medicine, PHYSICS IN MEDICINE AND BIOLOGY serves as an essential resource for researchers, professionals, and students alike, fostering innovation and enhancing collaboration in the healthcare sector. Although the journal is not currently open access, it maintains robust participation in the Scopus database, ranking #62 out of 333 in Radiology, Nuclear Medicine and Imaging and #17 out of 63 in Radiological and Ultrasound Technology, signifying its influence and reach within these disciplines.

Medical Dosimetry is a distinguished journal published by Elsevier Science Inc, dedicated to the advancing field of medical dosimetry and its applications within oncology, radiology, and nuclear medicine. With its ISSN 0958-3947 and E-ISSN 1873-4022, this journal serves as a crucial resource for researchers and professionals aiming to enhance their understanding of radiation treatment planning and dosage calculations. Encompassing a comprehensive range of topics from clinical dosimetry to technology assessment, Medical Dosimetry has been disseminating significant findings since its establishment in 1988, contributing to the continuous development of best practices in patient care and safety. The journal currently holds a Q3 ranking in various categories, reflecting its pivotal role in the research community, while not currently offering open access, it remains an essential reference for scholars advancing the techniques utilized in medical imaging and treatment. By fostering a platform for high-quality research, it aims to bridge the gap between theoretical studies and clinical applications, making it a vital addition to any medical library.

RADIATION PROTECTION DOSIMETRY is a vital academic journal dedicated to the field of radiation protection, published by Oxford University Press. With an ISSN of 0144-8420 and an E-ISSN of 1742-3406, this journal serves as a platform for groundbreaking research and developments in dosimetry, health physics, and radiation safety spanning over four decades since its inception in 1981. Recognized with a Q3 ranking in multiple categories including Medicine (miscellaneous) and Public Health, this journal plays a key role in disseminating important findings that inform policy, enhance practice, and promote the protection of both individuals and the environment from radiation hazards. While currently not available as Open Access, the journal's curated content is essential for researchers, professionals, and students dedicated to advancing knowledge in radiation protection and related areas. Interested readers will find the latest research trends, case studies, and reviews invaluable for their work and studies within this multidisciplinary domain.

Journal of Radiotherapy in Practice is a peer-reviewed journal published by Cambridge University Press, focusing on the evolving field of radiotherapy and its application in clinical practice. With ISSN 1460-3969 and E-ISSN 1467-1131, this journal serves as a critical platform for researchers, clinicians, and students in oncology and radiology, providing vital insights into treatment methodologies, patient care, and innovative practices. Although indexed in Q4 quartiles for both Oncology and Radiology, Nuclear Medicine and Imaging, the journal plays an essential role in disseminating clinical findings and advancing the science of radiotherapy since its inception in 1999. Authors are encouraged to contribute their research, case studies, and reviews that align with the journal's objectives, fostering a collaborative environment for sharing knowledge. Despite its current rankings, the journal aims to enhance its impact and visibility in the scientific community, thereby enriching professional practice and patient outcomes in the realm of radiotherapy.

Current Radiopharmaceuticals, published by Bentham Science Publishers Ltd, is an esteemed journal dedicated to advancing the field of radiopharmaceuticals. With an ISSN of 1874-4710 and an E-ISSN of 1874-4729, this journal has been a significant platform for researchers since its inception in 2009, and will continue to contribute to the literature until at least 2024. Current Radiopharmaceuticals is recognized for its impactful contributions, holding a record of Q3 in Pharmacology and Q2 in Radiology, Nuclear Medicine, and Imaging as of 2023, illustrating its vital role in these domains. The journal aims to provide a comprehensive overview of the latest techniques, applications, and innovations within the field of radiopharmaceutical science, catering to a diverse audience of researchers, professionals, and students. Despite its significant contributions, the journal remains committed to enriching the academic community with high-quality, peer-reviewed articles that can be accessed worldwide, reflecting a dedication to open dialogue and knowledge dissemination in radiopharmaceutical research.

Radiologic Technology, published by the American Society of Radiologic Technologists, serves as a pillar in the fields of radiology, nuclear medicine, and imaging, providing critical insights and advancements that shape the practice and profession. With an ISSN of 0033-8397 and E-ISSN 1943-5657, this esteemed journal has been contributing to the scholarly literature since 1963 and continues its commitment to quality research well into 2024. Although it is not an open-access journal, Radiologic Technology is recognized for its robust contributions, holding a Q3 quartile ranking in both "Radiological and Ultrasound Technology" and "Radiology, Nuclear Medicine, and Imaging," according to the latest 2023 category quartiles. Its Scopus rankings highlight its standing within the field, offering thought-provoking articles that encourage further exploration and innovation. As the landscape of medical imaging evolves, this journal remains a crucial resource for researchers, practitioners, and students aiming to enhance their understanding of radiologic technologies and their applications in modern healthcare.